Jury Says Sandoz Owes $39M For Eyelash Drug Infringement
Sandoz is liable for $39 million to Duke University and Allergan for infringing their patent for an eyelash-growth drug, a Colorado federal jury found Friday, upholding the patent's validity....To view the full article, register now.
Already a subscriber? Click here to view full article